MedPath
NMPA Approval

Compound Theophylline and Ephedrine Tablets

国药准字H22025992

April 10, 2020

Drug Information

复方茶碱麻黄碱片

片剂

复方

化学药品

April 10, 2020

Company Information

Applicant Company

Manufacturing Company

白城市长利街67-14号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方茶碱麻黄碱片 - NMPA 批准文号 | MedPath